Perfil epidemiológico de pacientes com leucemia mieloide aguda

Abstract

Leukemias consist of a group of malignant neoplasms whose main characteristic is the clonal expansion of immature hematopoietic progenitor cells that do not bleed in the bone marrow. They are divided into acute and chronic and myeloid and lymphoid (AML). Or present this study as an objective, write an integrative review on the epidemiological profile of patients with acute myeloid leukemia, which is based on the use of scientific papers available in the SciELO, LILACS and PubMed databases between the years 2015 and 2020, in Portuguese, English and Spanish. For the search for two articles, for the following descriptors: “Acute myeloid leukemia” and “Epidemiological profile”. Forms of the following inclusion criteria for the selection of two articles and papers: texts published in Portuguese, English (Acute myeloid leukemia, Health Profile) and Spanish (Acute Myeloid Leukemia, Health Profile), published in the period from 2015 to 2020. Two 26 items found, 21 were excluded from the investigation because they did not meet our inclusion criteria. Two 5 jobs included in the present study, there is a prevalence of jobs published in 2016 and 2017, both with 40% each, followed by 2018 with 20%. The higher the incidence of AML was in males, with AML M3 in September, respectively, or the most frequent subtype and cause of death. In studies with children with older children, the majority of cases were between 4 and 10 years old. Regarding ethnicity, 66.67%, two articles that address this characteristic, presenting individuals of white ethnicity. We found a growth trend, in addition to some studies that address the epidemiological profile of patients diagnosed with AML. Only two studies addressed two individuals with the most common subtype of AML survival. Based on the epidemiological data presented, this study can be used as an incentive in the construction and development of public policies for the diagnosis and treatment of AML. The constant updating of two epidemiological data will result in advances in the quality of care provided to these patients, contributing to an increase in the cure rate after death.